About NeoClone

苏州蚂蚁淘生物科技有限公司为NeoCloneX品牌在华授权代理商，公司不仅坚持提供传统标记的二抗（如酶标记，AMCA，FITC，罗丹明，Cy系列等），而且始终与*的染料生产商合作，以最快的速度供应新型染料标记的二抗（如Alexa Fluor，DyLight 405）。若您对Neoclone INCX产品感兴趣，请致电  0512-67156496 了解详情

NeoClone's Management Team Deven McGlenn - Chief Executive Officer Deven McGlenn is CEO of NeoClone and has been involved with the company since inception in 1999 and full-time since April 2002. During his tenure he has grown the business to $7M+ in revenues, 15+ FTEs and raised over $2.5M in equity. Prior to NeoClone, he was a management consultant for Arthur Andersen where he helped Fortune 500 companies develop a strategic view of their risk profiles. Before Andersen, he was the founder and CEO of an environmental remediation firm headquartered in the Midwest. Deven has a BS in Political Science with a minor in Business Administration from Marquette University. Contact Deven directly.   Mark Sullivan, PhD - Director of Phage Technologies Dr. Sullivan is the Director of Phage Technologies at NeoClone.  He has years of experience manipulating immunoglobulin molecules to develop novel reagents using phage antibody technology.  Dr. Sullivan is an expert in the creation of scFv libraries using novel strategies that eliminate common problems associated with production and use of complex Ab libraries. Mark has worked at the University of Rochester, Johnson & Johnson and Eastman Kodak. He received his PhD from the University of Wisconsin-Madison and his BS from Purdue University. For questions relating to antibody phage display, please contact Mark.